USE OF LCK INHIBITOR FOR TREATMENT OF IMMUNOLOGIC DISEASES

Details for Australian Patent Application No. 2003255413 (hide)

Owner Boehringer Ingelheim Pharma GmbH AND Co. KG

Inventors COLBATZKY, Florian; ERNEST, Steffen; HECKEL, Armin; STEFANIC, Martin, Friedrich; WALTER, Rainer; ROTH, Gerald, Jurgen; HAUPTMANN, Rudolf; HILBERG, Frank

Pub. Number AU-A-2003255413

PCT Number PCT/EP03/08890

PCT Pub. Number WO2004/017948

Priority 102 37 423.6 16.08.02 DE

Filing date 11 August 2003

Wipo publication date 11 March 2004

International Classifications

A61K 031/00

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 102 37 423.6 16.08.02 DE

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2003255413

5 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255414-RECIPROCATING PISTON ENGINE AND PISTON THEREFOR

2003255412-Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them